Tamsulosin
DrugOther names: Flomax
NCT Number: NCT02958878
Double blinded, randomized controlled prospective study looking at 2 preoperative doses of Tamsulosin an alpha-adrenergic blocker in preventing post-operative urinary retention. A previous study was conducted called "Effectiveness of tamsulosin inprevention of postoperative urinary retention: a randomized double-blind-placebo controlled study" This study involved a tertiary care center involving mostly urological surgical procedures. We look to specifically look at inguinal hernia surgeries in males. The aim of this study is to compare the prophylactic effect of tamsulosin with placebo on postoperative urinary retention. The drug is FDA approved for benign prostatic hypertrophy and urinary retention. It is on formulary at Genesys. Currently there is no standard procedure of prophylactic tamsulosin for urinary retention. Most often post operative patients are given tamsulosin to augment smooth muscle relaxation and spontaneous voiding if the patient is having urinary retention post operatively. We often straight catheterize patients once and start tamsulosin with the goal of avoiding urinary retention and future straight catheterizations or placement of foley catheters
Looking for future studies?
Notify Me30 year and older
Male
Interventional
Phase 4
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Flomax
Time frame: within 72 hours of surgery
If patients have urinary retention post operatively
Time frame: within 72 hours of surgery
Ascension Health
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06258785
Postoperative Urinary Retention, Reconstructive Pelvic Surgery
Skokie, Illinois, United States
View Trial DetailsNCT05276804
Postoperative Urinary Retention
Charlotte, North Carolina, United States
View Trial DetailsNCT05969145
Postoperative Urinary Retention
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05428020
Postoperative Urinary Retention, Total Hip Arthroplasty
Chicago, Illinois, United States
View Trial Details